Decrease of interleukin 6 during the first 12 months is a prognostic marker for clinical outcome during 36 months treatment with disease-modifying anti-rheumatic drugs (Q58043487)
scientific article published on 01 December 1997
Language:
(P31) (Q13442814)
(P50) (Q37829852)
(P304) 1298-1303
(P407) (Q1860)
(P433) 12
(P478) 36
(P577) Monday, December 1, 1997
(P921) (Q194908)
(P1433) (Q27709787)
(P1476) "Decrease of interleukin 6 during the first 12 months is a prognostic marker for clinical outcome during 36 months treatment with disease-modifying anti-rheumatic drugs" (language: en)
(P2093) T Lichtinger
J Schölmerich
H Menninger
B Lang
U Müller-Ladner
other details
description scientific article published on 01 December 1997

External Links